Related Experiment Video
Updated: Jun 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Triggering receptor (TREM-1) expressed on myeloid cells predicts bacteremia better than clinical variables in
Agustin Ruiz-González1, Aureli Esquerda, Miquel Falguera
1Department of Internal Medicine, Arnau de Vilanova University Hospital, Institut de Recerca Biomédica de Lleida, Lleida, Spain. agustinruiz@saludalia.com
Background And Objective:
Some clinical variables are associated with bacteremia in patients with community-acquired pneumonia (CAP). The aim of this study was to analyse the accuracy of the soluble form of triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict positive blood cultures in comparison with established clinical prognostic variables.
Methods:
In addition to collecting clinical and laboratory information, a commercially available immunoassay kit was used to measure the serum sTREM-1 levels on the first day of admit ion in patients with CAP. Receiver operating characteristic (ROC) curves were used to compare the ability of sTREM-1 and commonly used clinical variables to identify bacteremia.
Results:
Blood cultures yielded a pathogen in 13 (10.4%) out of 124 patient samples. The microorganisms isolated were Streptococcus pneumoniae (11 patients) and Klebsiella pneumoniae (2 patients). The presence of pleuritic chest pain, tachycardia and extreme white cell count (WCC) were associated with bacteremia. However, ROC curve analysis showed an accuracy of sTREM-1 (area under the receiver operating characteristic curve (AUC) 0.84, 95% CI: 0.72-0.95), which was higher than pleuritic chest pain (AUC 0.71, 95% CI: 0.57-0.84), tachycardia (AUC 0.73, 95% CI: 0.58-0.88) and extreme WCC (AUC 0.70, 95% CI: 0.55-0.85) for predicting positive blood cultures. Low admission sTREM-1 serum values had a high negative predictive value for excluding bacteremia (sTREM-1 <120 pg/mL = 98.8%).
Conclusions:
This preliminary study suggests that the determination of sTREM-1 serum levels on admission may be more accurate than clinical variables for identifying bacteremic patients.
Insights
Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) serum levels show higher accuracy than clinical factors in predicting bacteremia in community-acquired pneumonia (CAP) patients. This biomarker may improve early identification of bloodstream infections.
Area of Science:
- Infectious Diseases
- Immunology
- Critical Care Medicine
Background:
- Bacteremia is a serious complication of community-acquired pneumonia (CAP).
- Established clinical variables have limitations in accurately predicting bacteremia in CAP patients.
- The diagnostic utility of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) for bacteremia in CAP requires further investigation.
Purpose of the Study:
- To evaluate the accuracy of serum sTREM-1 levels in predicting positive blood cultures in CAP patients.
- To compare the predictive performance of sTREM-1 against established clinical prognostic variables.
Main Methods:
- Serum sTREM-1 levels were measured using an immunoassay on admission in CAP patients.
- Clinical and laboratory data were collected for all participants.
- Receiver operating characteristic (ROC) curve analysis was employed to assess the diagnostic accuracy of sTREM-1 and clinical variables for bacteremia.
Main Results:
- Bacteremia was identified in 10.4% of CAP patients, primarily by Streptococcus pneumoniae.
- sTREM-1 demonstrated a higher area under the ROC curve (AUC=0.84) for predicting bacteremia compared to pleuritic chest pain (AUC=0.71), tachycardia (AUC=0.73), and extreme white cell count (AUC=0.70).
- Low admission sTREM-1 levels (<120 pg/mL) exhibited a high negative predictive value (98.8%) for excluding bacteremia.
Conclusions:
- Serum sTREM-1 levels may serve as a more accurate biomarker than traditional clinical variables for identifying bacteremic CAP patients.
- This preliminary study highlights the potential of sTREM-1 as a valuable tool for early bacteremia detection in CAP.
- Further research is warranted to validate these findings in larger cohorts.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Pneumonia III: Complications and Assessment
Bacterial Meningitis
Atypical Pneumonia
Bacterial Meningitis I: Introduction
Pneumonia I: Introduction